Lulu joined the GI Microbiota research and Therapeutics team in March of 2022. With a couple of years of administrative work experience and her passion for learning how Fecal Microbiota Transplant affects IBD patients, she is excited to have more participants join the studies.

Lulu enjoys playing piano and some outdoor time with her family in her spare time.